4/A
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-20-028690
Chief Financial Officer sold 15,000 shares at an average $24.47 ($367,029)
- Chief Financial Officer acquired 15,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cohen Chad M Chief Financial Officer | 2020-04-08 | Option exercise | +5,000 | $6.32 | $31,600 | 6,000 | D |
| Cohen Chad M Chief Financial Officer | 2020-04-08 | Option exercise | +10,000 | $4.07 | $40,700 | 16,000 | D |
| Cohen Chad M Chief Financial Officer | 2020-04-08 | Sale | −9,700 | $24.14 | $234,158 | 6,300 | D |
| Cohen Chad M Chief Financial Officer | 2020-04-08 | Sale | −5,300 | $25.07 | $132,871 | 1,000 | D |
| Derivatives | |||||||
| Cohen Chad M Chief Financial Officer | 2020-04-08 | Option exercise · Stock Option (Right to Buy) | −10,000 | 35,000 | D | ||
| Cohen Chad M Chief Financial Officer | 2020-04-08 | Option exercise · Stock Option (Right to Buy) | −5,000 | 745,000 | D | ||
| Open-market sales · 15,000 sh · avg $24.47 · $367,029 | |||||||
Loading xslF345X03/doc4a.xml…